However, an analysis of the earlier studies shows that significant changes in the activity of PON-1 and MPO appear most often in the end stages of chronic kidney disease [31,32], which may explain the lack of significance in our moderately advanced group of patients with CKD. This evidence concerns the gene PON1 and chronic kidney disease.